CairnSurgical is developing innovative patient-specific tools to guide surgical interventions for patients with cancer.
CairnSurgical has raised $4.5M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
CairnSurgical's investors include Morningside.
CairnSurgical is headquartered in Lebanon, United States.
CairnSurgical is developing innovative patient-specific tools to guide surgical interventions for patients with cancer.
CairnSurgical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CairnSurgical — Funding & Investors." VCBacked, August 21, 2024, https://www.vcbacked.co/company/cairnsurgical. Accessed October 31, 2026.
VCBacked. (2024). CairnSurgical — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/cairnsurgical
{{cite web |title=CairnSurgical — Funding & Investors |url=https://www.vcbacked.co/company/cairnsurgical |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated